+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Benzodiazepine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4851700
  • Report
  • January 2019
  • Region: Global
  • 212 pages
  • Transparency Market Research
1 of 2

Benzodiazepine Drugs Market - Overview

Benzodiazepine are psychoactive drugs that are used to treat anxiety, insomnia, seizures, and alcohol withdrawal. The number of people affected with these diseases is increasing across the world. Factors such as exposure to stressful lifestyle, daily habits, and rise in geriatric population are major reasons for mental disturbance, which creates anxiety, maniac, and panic disorder conditions. People, presently, are more inclined toward prevention of these diseases. People seek relief and a calming effect to counter these conditions or symptoms. Benzodiazepine are considered to be highly effective drugs to control and calm these effects. These drugs are extensively prescribed across the world. The market for benzodiazepine drugs is expanding significantly due to an increase in prevalence of anxiety, seizures, insomnia, and rise in concern for prevention of stress and related conditions. Moreover, a comparatively higher number of prescriptions of benzodiazepine, as compared to other psychoactive drugs, and an increase in the rate of adoption of generic drugs have fuelled the benzodiazepine drugs market. The Alprazolam segment is anticipated to expand at a higher CAGR due to its wide application in anxiety, panic disorders, and higher number of prescriptions for the same.

 The benzodiazepine drugs market has been segmented based on product, application, time of action, distribution channel, and region. Based on product, the global market has been divided into Alprazolam, Clonazepam, Diazepam, Lorazepam, and others. In terms of application, the global benzodiazepine drugs market has been classified into anxiety, insomnia, alcohol withdrawal, seizures, and others. Based on time of action, the global market has been segregated into ultra-short acting, short acting, and long acting. In terms of distribution channel, the global benzodiazepine drugs market has been split into hospital pharmacies, retail pharmacies and others. Each of the segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities and useful insights. The report gives current and future market size for each segment and sub segments for the period from 2018 to 2026 in terms of value in US$ Mn, considering 2017 as the base year. The compound annual growth rate (%CAGR) has been provided for each segment and market for the period of 2018 to 2026 with market size estimations.

In terms of region, the global market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The regions have been further sub-segmented into major countries and sub-regions. The current and future market sizes in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2016 to 2026, with their growth rate (%) for the period from 2018 to 2026. The study also offers a list of recommendations, highlights and some useful insights of the market that would surely help new companies willing to enter the market and for existing companies to increase market shares, which in turn is likely to help in the decision-making process.

The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints, opportunities and key trends that influence the current and future status of the benzodiazepine drugs market. The report also covers market value projections, market attractiveness analysis, and key market share analysis in the market overview section in order to provide a thorough analysis of the overall competitive scenario of the global benzodiazepine drugs market.

The report concludes with the company profiles section that includes key information about the major players in the market. Key players identified in this report are Pfizer Inc., F.Hoffmann-La Roche Ltd., Bausch Health Companies, Inc., Mylan, N.V., Teva Pharmaceutical Industries Ltd., H.Lundbeck A/S, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Apotex Inc., and Aurobindo Pharma. Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, Business segments and recent developments.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Benzodiazepine Drugs Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Benzodiazepine Drugs Market Analysis and Forecast, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Regulatory Scenario by Region/globally
5.2. Pipeline Analysis
5.3. Overview of Growing Benzodiazepine Drug Misuse

6. Global Benzodiazepine Drugs Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Benzodiazepine Drugs Market Value Forecast, by Product, 2016-2026
6.3.1. Alprazolam
6.3.2. Clonazepam
6.3.3. Diazepam
6.3.4. Lorazepam
6.3.5. Others
6.4. Global Benzodiazepine Drugs Market Attractiveness, by Product

7. Global Benzodiazepine Drugs Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Benzodiazepine Drugs Market Value Forecast, by Application, 2016-2026
7.3.1. Anxiety
7.3.2. Insomnia
7.3.3. Alcohol Withdrawal
7.3.4. Seizures
7.3.5. Others
7.4. Global Benzodiazepine Drugs Market Attractiveness, by Application

8. Global Benzodiazepine Drugs Market Analysis and Forecast, by Time of Action
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Global Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016-2026
8.3.1. Ultra-short Acting
8.3.2. Short Acting
8.3.3. Long Acting
8.4. Global Benzodiazepine Drugs Market Attractiveness, by Time of Action

9. Global Benzodiazepine Drugs Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Global Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016-2026
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Others
9.4. Global Benzodiazepine Drugs Market Attractiveness, by Distribution Channel

10. Global Benzodiazepine Drugs Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Benzodiazepine Drugs Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East and Africa
10.3. Global Benzodiazepine Drugs Market Attractiveness, by Region

11. North America Benzodiazepine Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Benzodiazepine Drugs Market Value Forecast, by Product, 2016-2026
11.2.1. Alprazolam
11.2.2. Clonazepam
11.2.3. Diazepam
11.2.4. Lorazepam
11.2.5. Others
11.3. North America Benzodiazepine Drugs Market Value Forecast, by Application, 2016-2026
11.3.1. Anxiety
11.3.2. Insomnia
11.3.3. Alcohol Withdrawal
11.3.4. Seizures
11.3.5. Others
11.4. North America Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016-2026
11.4.1. Ultra-short Acting
11.4.2. Short Acting
11.4.3. Long Acting
11.5. North America Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016-2026
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Others
11.6. North America Benzodiazepine Drugs Market Value Forecast, by Country, 2016-2026
11.6.1. U.S.
11.6.2. Canada
11.7. North America Benzodiazepine Drugs Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By Time of Action
11.7.4. By Distribution Channel
11.7.5. By Country

12. Europe Benzodiazepine Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Benzodiazepine Drugs Market Value Forecast, by Product, 2016-2026
12.2.1. Alprazolam
12.2.2. Clonazepam
12.2.3. Diazepam
12.2.4. Lorazepam
12.2.5. Others
12.3. Europe Benzodiazepine Drugs Market Value Forecast, by Application, 2016-2026
12.3.1. Anxiety
12.3.2. Insomnia
12.3.3. Alcohol Withdrawal
12.3.4. Seizures
12.3.5. Others
12.4. Europe Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016-2026
12.4.1. Ultra-short Acting
12.4.2. Short Acting
12.4.3. Long Acting
12.5. Europe Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016-2026
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Others
12.6. Europe Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016-2026
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Europe Benzodiazepine Drugs Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By Time of Action
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region

13. Asia Pacific Benzodiazepine Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Product, 2016-2026
13.2.1. Alprazolam
13.2.2. Clonazepam
13.2.3. Diazepam
13.2.4. Lorazepam
13.2.5. Others
13.3. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Application, 2016-2026
13.3.1. Anxiety
13.3.2. Insomnia
13.3.3. Alcohol Withdrawal
13.3.4. Seizures
13.3.5. Others
13.4. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016-2026
13.4.1. Ultra-short Acting
13.4.2. Short Acting
13.4.3. Long Acting
13.5. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016-2026
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Others
13.6. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016-2026
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. Australia & New Zealand
13.6.5. Rest of APAC
13.7. Asia Pacific Benzodiazepine Drugs Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By Time of Action
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region

14. Latin America Benzodiazepine Drugs Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Benzodiazepine Drugs Market Value Forecast, by Product, 2016-2026
14.2.1. Alprazolam
14.2.2. Clonazepam
14.2.3. Diazepam
14.2.4. Lorazepam
14.2.5. Others
14.3. Latin America Benzodiazepine Drugs Market Value Forecast, by Application, 2016-2026
14.3.1. Anxiety
14.3.2. Insomnia
14.3.3. Alcohol Withdrawal
14.3.4. Seizures
14.3.5. Others
14.4. Latin America Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016-2026
14.4.1. Ultra-short Acting
14.4.2. Short Acting
14.4.3. Long Acting
14.5. Latin America Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016-2026
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Others
14.6. Latin America Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016-2026
14.6.1. Brazil
14.6.2.Mexico
14.6.3. Rest of LATAM
14.7. Latin America Benzodiazepine Drugs Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By Time of Action
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region

15. Middle East & Africa Benzodiazepine Drugs Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Product, 2016-2026
15.2.1. Alprazolam
15.2.2. Clonazepam
15.2.3. Diazepam
15.2.4. Lorazepam
15.2.5. Others
15.3. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Application, 2016-2026
15.3.1. Anxiety
15.3.2. Insomnia
15.3.3. Alcohol Withdrawal
15.3.4. Seizures
15.3.5. Others
15.4. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016-2026
15.4.1. Ultra-short Acting
15.4.2. Short Acting
15.4.3. Long Acting
15.5. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016-2026
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Others
15.6. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016-2026
15.6.1. GCC Countries
15.6.2.South Africa
15.6.3. Rest of MEA
15.7. Middle East & Africa Benzodiazepine Drugs Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Application
15.7.3. By Time of Action
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region

16. Competition Landscape
16.1.Market Player - Competition Matrix (By Tier and Size of companies)
16.2.Market Share Analysis By Tier and Size of the Company (2017)
16.3. Company Profiles
16.3.1. Pfizer Inc.
16.3.2. F.Hoffmann-La Roche Ltd.
16.3.3. Bausch Health Companies, Inc.
16.3.4. Mylan N.V.
16.3.5. Teva Pharmaceutical Industries Ltd.
16.3.6. H.Lundbeck A/S
16.3.7. Amneal Pharmaceuticals LLC
16.3.8. Sun Pharmaceutical Industries Ltd.
16.3.9. Apotex Inc.
16.3.10. Aurobindo Pharma
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll